New insider activity at Tenet Healthcare ( (THC) ) has taken place on May 17, 2025.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Executive Vice President and Chief Information Officer Paola M Arbour recently sold 6,461 shares of Tenet Healthcare stock, amounting to a total transaction value of $1,035,052.
Recent Updates on THC stock
In the last 24 hours, Tenet Healthcare’s stock has seen multiple price target increases from various analysts, driven by strong Q1 results and strategic company developments. BofA raised its price target due to a bullish outlook following discussions with Tenet’s leadership, highlighting confidence in strategic goals and peer multiples. Truist updated its price target reflecting Q1 results and revised guidance. RBC Capital increased its target based on Tenet’s significant operating leverage and strong EBITDA performance. UBS cited labor efficiencies and the potential of high-acuity ambulatory surgery centers as reasons for their target increase. Guggenheim also raised its target, emphasizing the company’s substantial EBITDA upside and a strong start to 2025, despite potential headwinds.
Spark’s Take on THC Stock
According to Spark, TipRanks’ AI Analyst, THC is a Outperform.
Tenet Healthcare demonstrates strong financial performance and technical momentum, with an attractive valuation. Key strengths include robust EBITDA growth and strategic capital management. However, the company must address revenue growth challenges and policy uncertainties to sustain this performance.
To see Spark’s full report on THC stock, click here.
More about Tenet Healthcare
YTD Price Performance: 30.99%
Average Trading Volume: 1,692,329
Technical Sentiment Signal: Buy
Current Market Cap: $14.82B